Abstract:Introduction: Gitelman syndrome(GS) is a rare inherited tubular disorder which is characterized by hypokalemia, metabolic alkalosis, hypomagnesemia, and hypocalciuria. Here, we report a case of schizophrenia-like psychosis concomitant with GS and related literatures are reviewed.Case description: An 18-year-old male patient with 1-week history of auditory hallucinations, sense of insecurity, delusions of reference and feelings of being followed and controlled by others unknown, insomnia was admitted to Psychiatry department in December, 2013. Hypokalemia and hypomagnesemia were noted. He was diagnosed as schizophrenia-like psychosis. Treatment with paliperidone at the dose of 6 mg/day and magnesium and potassium supplementations was commenced. However, electrolyte disturbances failed to improve following psychosis remission. Therefore, other underlying diseases resulting in electrolyte disturbances were suspected. Along with hypokalemia and hypomagnesemia, additional investigation showing metabolic alkalosis, hypocalciuria, renal loss of potassium, were consistent with GS. Gene analysis revealed this patient carried out c. 2687 G > A homozygous mutation of exon 23 in the SLC12A3 gene which led to p.Arg896Gln. Eventually, GS was identified. Thus, additional spironolactone (40 mg/day) combined with increased doses of oral potassium chloride sustained-release tablets (3.0 g/day) and potassium magnesium aspartate (0.3 g/day) were administered. During next half a year, fatigue resolved, paliperidone gradually tapered and eventually discontinued while psychosis maintained complete remission. His serum potassium was near normal (3.2-3.5 mmol/L), hypomagnesemia significantly improved (0.57-0.67 mmol/L).Discussion and evaluation: Electrolyte abnormalities secondary to GS might cause or contribute to development of neuropsychiatric symptoms. In turn, hypokalemia was common among acute psychiatric inpatients. As a consequence, when concomitant with psychosis, GS was readily concealed.Conclusion: Electrolyte disturbances are common in acute psychiatric patients. However, when electrolyte disturbances are not improved following psychosis remission, other underlying diseases such as GS should be considered.

Bartter Syndrome Type III with Glomerular Dysplasia and Chronic Kidney Disease: A Case Report.

A Chinese Girl with Bartter Syndrome Type III Due to a Novel Mutation And/or Single Nucleotide Polymorphisms (snps) in CLCNKB Gene

Bartter Syndrome Type III with Only a Synonymous Mutation of the CLCNKB Gene

A New Case Report of a CLCNKB Complex Heterozygous Mutation in Adult-Onset Type III Bartter Syndrome

Adult classic Bartter syndrome: a case report with 5-year follow-up and literature review

A Novel CLCNKB Variant in a Chinese Family with Classic Bartter Syndrome and Prenatal Genetic Diagnosis.

A Novel Mutation Associated with Type III Bartter Syndrome: A Report of Five Cases.

Splicing Characterization of CLCNKB Variants in Four Patients with Type III Bartter Syndrome

Digenetic Inheritance of SLC12A3 and CLCNKB Genes in a Chinese Girl with Gitelman Syndrome

A Novel Splicing Mutation in Clcnkb in A Chinese Patient with Bartter Syndrome Type Iii

The Bartter-Gitelman Spectrum: 50-Year Follow-up With Revision of Diagnosis After Whole-Genome Sequencing

Schizophrenia-like Psychosis and Gitelman Syndrome: a Case Report and Literature Review.

Genetic heterogeneity in patients with Bartter syndrome type 1.

Digenic Mutations Involving Both the BSND and GJB2 Genes Detected in Bartter Syndrome Type IV.

Bartter syndrome-like phenotype in a patient with type 2 diabetes mellitus

Simultaneous Homozygous Mutations in SLC12A3 and CLCNKB in an Inbred Chinese Pedigree

ClC-Kb pore mutation disrupts glycosylation and triggers distal tubular remodeling

[Advance in Genetic Research on Gitelman Syndrome].

Novel Compound Heterozygousclcnkbgene Mutations (c.1755a>g/c.848_850deltct) Cause Classic Bartter Syndrome

Novel SLC12A1 mutations cause Bartter syndrome in two patients with different prognoses

Hypocalcemia as the Initial Presentation of Type 2 Bartter Syndrome–A Family Report